Papers
5
Total Citations
83
H-Index
4
About
Rajender Kumar is a pioneering researcher in nuclear medicine and interventional oncology, whose work centers on the integration of advanced PET/CT imaging with robotic-assisted biopsy techniques. His major contributions lie in revolutionizing prostate cancer diagnosis through the use of 68Ga-PSMA PET/CT-guided biopsies, demonstrating that this targeted approach can significantly improve diagnostic yield over traditional methods. His landmark 2022 study on robotic-assisted transgluteal prostatic biopsy (38 citations) has set a new standard for precision in prostate cancer detection. Kumar has also been instrumental in validating a biopsy-free diagnostic pathway by combining multi-parametric MRI with PSMA PET-CT, a concept explored in his 2023 work (14 citations). Beyond prostate cancer, he has advanced the safety and accuracy of PET/CT-guided biopsies using automated robotic arms, while carefully quantifying radiation exposure to personnel (13 citations). His recent phase 2 trial on [18F]NaF PET/CT-guided intraarticular blocks for facet joint arthropathy (2025) showcases his expanding scope into pain management. With a growing citation impact, Kumar is shaping the future of minimally invasive, image-guided diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5